Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Observational Study to Validate the SpotitEarly Test for the Detection of Breast Cancer (The PINK Study)

NCT07038785 is registered in ClinicalTrials.gov with SpotitEarly as lead sponsor.

NCT NCT07038785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07038785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Observational Study to Validate the SpotitEarly Test for the Detection of Breast Cancer (The PINK Study)
Lead sponsor
SpotitEarly
Phase
Observational
Overall status
Recruiting
Start date
July 22, 2025
Completion date
June 30, 2027
Enrollment
1,204 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer